ALEXION PHARMACEUTICALS INC 4
4 · ALEXION PHARMACEUTICALS INC · Filed Dec 13, 2016
Insider Transaction Report
Form 4
Thiel Carsten
EVP, Chief Commercial Officer
Transactions
- Sale
Common Stock, par value $.0001 per share
[F1]2016-12-09$130.00/sh−2,308$300,040→ 30,433 total
Footnotes (1)
- [F1]This transaction was made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
Signature
/s/ Michael Greco, Attorney-in-Fact for Carsten Thiel|2016-12-13